StockGuru Spotlight on diaDexus, Inc.
(Symbol: DDXS)
Help us update information on this company. Email any updates to: [email protected]
About diaDexus, Inc.:
diaDexus, Inc., based in South San Francisco, California, develops and commercializes proprietary cardiovascular diagnostic products addressing unmet needs in cardiovascular disease. The company’s PLAC Test ELISA Kit is the only blood test cleared by the FDA to aid in predicting risk for both coronary heart disease and ischemic stroke associated with atherosclerosis, the #1 and #3 causes of death, respectively, in the United States. The company’s PLAC Test for Lp-PLA2 Activity, a CE-marked test, is an indicator of atherosclerotic cardiovascular disease, the #1 cause of death in Europe. diaDexus is ISO 13485 certified and is manufacturing the PLAC Test for Lp-PLA2 Activity on-site.
Where it is located:
349 Oyster Point Boulevard South
San Francisco, CA
94080
United States
Key Executive Contact:
Micheal Richey
CBO
Ninety Day Volume:
78705 (as of date of publication)
Ninety Day Dollar Volume:
$54,779
Share Information:
55153376 shares as of 2014-07-31
Corporate Information:
State Incorporated: DE
Country Incorporated: USA
Contact, Website and Social Media for diaDexus, Inc.:
Shown Where Available
Website: http://www.diadexus.com
Facebook:
Twitter:
LinkedIn:
Telephone: (650) 246-6400
Email: [email protected]